ImmunityBio, Inc. (IBRX)

ImmunityBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.24	143.43	265.45	104.64	181.1	34.92
Short-Term Investments	197.57	6.38	1.01	2.54	136.02	61.15
Cash & Short-Term Investments	257.81	149.81	266.46	107.18	317.12	96.06
Cash Growth	97.76%	-43.78%	148.60%	-66.20%	230.12%	49.28%
Accounts Receivable	32.02	2.36	-	-	-	-
Other Receivables	1.7	0.29	3.17	1.89	1.33	2
Receivables	33.72	2.65	3.17	1.89	1.33	2
Inventory	6.7	8.27	-	2.16	-	-
Prepaid Expenses	19.02	16.73	13.98	14.74	12.25	13.65
Other Current Assets	12.25	7.12	10.47	14.6	3.65	-
Total Current Assets	329.5	184.59	294.08	140.58	334.35	111.71
Property, Plant & Equipment	163.08	170.46	182.68	189.58	119.17	90.68
Long-Term Investments	0.7	-	0.89	0.84	7.6	11.4
Goodwill	0.91	0.91	-	-	-	-
Other Intangible Assets	13.57	15.02	17.09	20	1.42	1.46
Other Long-Term Assets	3.92	4.83	2.82	4.73	-	-
Total Assets	518.99	382.93	504.45	362.36	468.91	221.38
Accounts Payable	5.77	6.73	9.2	21.02	11.42	11.51
Accrued Expenses	39.33	37.91	39.53	34.23	33.94	33.99
Short-Term Debt	2.6	1.25	1.48	433.32	301.83	-
Current Portion of Leases	7.37	7.47	5.31	2.73	3.01	5.02
Other Current Liabilities	2.07	1.6	2.77	9.57	18.8	17.62
Total Current Liabilities	57.13	54.94	58.28	500.86	369	68.13
Long-Term Debt	816.95	746.28	836.95	241.27	306.35	254.35
Long-Term Leases	34.37	34.82	39.94	48.02	37.07	16.18
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.17
Other Long-Term Liabilities	133.94	35.01	155.21	22.03	0.41	1.04
Total Liabilities	1,042	871.06	1,090	812.18	712.82	339.87
Common Stock	0.1	0.09	0.07	0.04	0.04	0.04
Additional Paid-In Capital	3,135	2,885	2,375	1,931	1,720	1,495
Retained Earnings	-3,665	-3,375	-2,962	-2,378	-1,962	-1,615
Comprehensive Income & Other	5	1.2	0.01	0.18	0	0.12
Total Common Equity	-524.32	-489.1	-586.99	-447.33	-242.17	-119.81
Minority Interest	0.91	0.97	1.05	-2.49	-1.74	1.32
Shareholders' Equity	-523.41	-488.13	-585.94	-449.82	-243.91	-118.49
Total Liabilities & Equity	518.99	382.93	504.45	362.36	468.91	221.38
Total Debt	861.29	789.82	883.68	725.33	648.26	275.55
Net Cash (Debt)	-603.48	-640.01	-616.32	-617.31	-330.32	-178.54
Net Cash Per Share	-0.71	-0.91	-1.21	-1.54	-0.85	-0.47
Filing Date Shares Outstanding	984.97	853.44	673.95	435.84	397.91	333.96
Total Common Shares Outstanding	984.97	852.9	670.87	421.57	397.83	333.96
Working Capital	272.36	129.64	235.8	-360.28	-34.65	43.58
Book Value Per Share	-0.53	-0.57	-0.87	-1.06	-0.61	-0.36
Tangible Book Value	-538.79	-505.03	-604.08	-467.33	-243.59	-121.27
Tangible Book Value Per Share	-0.55	-0.59	-0.90	-1.11	-0.61	-0.36
Buildings	-	-	-	-	-	22.69
Machinery	77.74	75.44	71.8	69.85	55.34	35.75
Construction In Progress	86.27	86.42	84.44	72.69	16.58	1.33
Leasehold Improvements	73.15	73.13	72.55	68.71	62.48	52.25

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q